ipilimumab (MedChemExpress)
Structured Review

Ipilimumab, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ipilimumab/product/MedChemExpress
Average 93 stars, based on 5 article reviews
Images
1) Product Images from "CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy"
Article Title: CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy
Journal: Frontiers in Oncology
doi: 10.3389/fonc.2025.1670033
Figure Legend Snippet: Effects of different treatments on cell proliferation. (A) Proliferation of A2780 cells under indicated treatments (A2780: untreated cells, A2780+N+I: A2780+Nivolumab+Ipilimumab, A2780+N+I+CIK: A2780+Nivolumab+Ipilimumab+CIK cells. (B) Proliferation of SKOV3 cells under indicated treatments (SKOV3, SKOV3+N+I, SKOV3+N+I+CIK). Cell proliferation was assessed by measuring OD values at 450 nm. n=3, **=0.004, **=0.0006, **=0.002, **=0.0001 vs. control group.
Techniques Used: Control